Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention

Thromb Haemost. 2024 Jun;124(6):595-597. doi: 10.1055/a-2216-5263. Epub 2023 Nov 22.

Authors

Marco Cattaneo^{1

2}, Alessandro Squizzato³, Simone Birocchi¹, Gian Marco Podda¹

Affiliations

¹ Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
² Fondazione Arianna Anticoagulazione, Bologna, Italy.
³ Research Center on Thromboembolic Disorders and Antithrombotic Therapies, ASST Lariana, University of Insubria, Como, Italy.

PMID: 37992750
DOI: 10.1055/a-2216-5263

No abstract available

Publication types

Letter
Comment

MeSH terms

Blood Platelets / drug effects
Humans
Incidence
Meta-Analysis as Topic
Percutaneous Coronary Intervention* / adverse effects
Platelet Function Tests
Postoperative Complications* / blood
Postoperative Complications* / epidemiology
Postoperative Complications* / etiology
Postoperative Complications* / prevention & control
Purinergic P2Y Receptor Antagonists* / administration & dosage
Purinergic P2Y Receptor Antagonists* / adverse effects
Randomized Controlled Trials as Topic
Receptors, Purinergic P2Y12 / metabolism
Systematic Reviews as Topic
Thrombosis* / blood
Thrombosis* / epidemiology
Thrombosis* / etiology
Thrombosis* / prevention & control

Substances

P2RY12 protein, human
Purinergic P2Y Receptor Antagonists
Receptors, Purinergic P2Y12